CTMX CytomX Therapeutics, Inc.
Healthcare$3.76+0.00%ClosedMarket Cap: $604.7M
As of 2026-05-25
Insider Statistics (Q1 2026)
Acquisitions
11
Dispositions
4
Buy/Sell Ratio
2.75
Net Shares
+2,218,937
Shares Acquired
2,410,000
Shares Disposed
191,063
Total Bought ($)
$0.00
Total Sold ($)
$4.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu Mar 19 | Ogden Christopher | officer: Chief Financial Officer | Sell | 19,323 | $6.42 | 296,948 |
| Thu Mar 19 | McCarthy Sean A. | director, officer: CEO | Sell | 118,969 | $6.42 | 1,078,922 |
| Thu Mar 19 | Chu Yu-Waye | officer: Chief Medical Officer | Sell | 21,279 | $6.42 | 189,446 |
| Thu Mar 19 | BELVIN MARCIA | officer: SVP, Chief Scientific Officer | Sell | 31,492 | $6.42 | 300,760 |
| Wed Feb 04 | Lester Rachael | officer: Chief Business Officer | Sell | 50,000 | $0.00 | 50,000 |
| Wed Feb 04 | Lester Rachael | officer: Chief Business Officer | Sell | 20,000 | $0.00 | 20,000 |
| Wed Feb 04 | Chu Yu-Waye | officer: Chief Medical Officer | Sell | 300,000 | $6.09 | 300,000 |
| Wed Feb 04 | Chu Yu-Waye | officer: Chief Medical Officer | Sell | 75,000 | $0.00 | 210,725 |
| Wed Feb 04 | BELVIN MARCIA | officer: SVP, Chief Scientific Officer | Sell | 60,000 | $0.00 | 332,252 |